Navigation Links
MGT Capital Investments Reports First Quarter 2008 Financial Results and Provides Update on Recent Developments
Date:5/12/2008

NEW YORK, May 12 /PRNewswire-FirstCall/ -- MGT Capital Investments, Inc. (AMEX: MGT), a technology holding company focused on the Healthcare Information Technology ("HCIT") sector, today reported financial results for the first quarter ended March 31, 2008, and provided an update on strategic milestones.

Tim Paterson-Brown, MGT Chairman and CEO, stated, "We anticipate 2008 will be a significant turning point for our subsidiaries, Medicsight and Medicexchange. In the first quarter, Medicsight increased the reach of its technology through key strategic partnerships including Toshiba. We believe that the value of our subsidiaries' businesses and underlying technologies are not reflected in our share price. As such, our Board authorized a buyback of up to 1 million shares of MGT stock which is now largely complete, and we have completed the repurchase of a block of 5.35 million restricted shares.

"In the coming months, we intend to increase our investor outreach in order to raise awareness of the value we believe our shares currently offer and potential value we are looking to build for our shareholders.

"We recently announced approval from the Chinese State Food and Drug Administration ("SFDA") for our MedicRead Colon workstation, and we plan to launch this workstation via our extensive Chinese dealer network. Our CAD software has been validated against an extremely diverse geographic, gold standard read database and in numerous clinical trials over the past several years. Between this and our patents, we believe there is a significant barrier to entry for competitors, giving us an advantage within our space, and confidence in our gaining widespread approval."

Recent Developments

-- In April 2008, MGT'
'/>"/>

SOURCE MGT Capital Investments, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Launch of Fountain Healthcare Partners, a Life Science Venture Capital Firm
2. Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement
3. SPO Medical Retains American Capital Ventures for Investor Relations Services
4. MichBio Will Host Workshop on Capital Formation Prior to April 22 Annual Meeting
5. CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection
6. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
7. RiverVest Venture Partners(R), a St. Louis-Based Venture Capital Firm Focusing on Life Sciences, Closes on Fund II, Names John P. McKearn, Ph.D., Venture Partner
8. Biotech Avoids Fall Out From Tough Quarter for Capital Markets
9. Plethora and Paul Capital Healthcare sign a $25 million revenue interest financing agreement with an option for an additional $3 million equity investment
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Pharmasset Receives $10 Million of Working Capital

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)...ewswire-FirstCall/ -- BioSpecifics Technologies Co...developing first-in-class collagenase-based produc...third quarter ended September 30, 2009. ,, "We...ear, the FDA,s Arthritis Advisory Committee unanim... of XIAFLEX(TM) for the treatment of Dupuytren,s d...
(Date:11/5/2009)...wswire/ -- SpineSmith Partners has signed an initi...nique scaffold that mimics the structure of natura...l commercial products by SpineSmith,s Research and...GenOsteo scaffold represents a significant advance... environment for the delivery of adult stem cells ...
(Date:11/4/2009)...binar, which will be presented on November 19 and ...w chemistry processing, will deal with the applica... meso and micro scale flow chemistry equipment. P...een recognized with several prestigious prizes and...ron Prize. , Columbia, MD...
(Date:11/4/2009)... Onyx Pharmaceuticals, In...resent at the Credit Suisse 18th Annual Healthcare.... Mountain Time (8:30 a.m. Pacific Time). Interes...ntation on our website at: http://www.onyx-pharm...mmended that listeners log on 15 minutes early in ...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 2Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology' 3
... Feb. 4 Art,s Way Manufacturing, Inc. (Nasdaq: ...,s Way Scientific, Inc. - Buildings For Science - ...sforscience.com/ The new site, reflective of the ..., clean and more user-friendly. , , Art,s Way Sci...a leading supplier of custom-designed modular labo...
... Offers New Understanding of Biological and Physic...ize Trust announces the Microgravity Research Comp...avity to advance biotech, nanotech, combustion, me...t and Space Exploration Technologies (SpaceX), the...tion to and from Low Earth Orbit for the winning e...
.... 4 GeoVax Labs, Inc.,(OTC Bulletin Board: GOVX),...al company developing human vaccines for diseases ... other infectious agents, today,announced that its...tor Conference,2009 will be webcast live by Thomso...orf-Astoria Hotel in New York City on February 9 a...
Other Biology Technology:Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 2Art's Way Manufacturing Announces Launch of New Web Site For Art's Way Scientific - Buildings For Science 3Heinlein Trust and SpaceX Announce Competition to Promote Research Innovation in Zero Gravity 2Heinlein Trust and SpaceX Announce Competition to Promote Research Innovation in Zero Gravity 3GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference 2GeoVax to Webcast Its Presentation at the BIO CEO & Investor 2009 Conference 3
(Date:11/6/2009)...ETROIT, Nov. 6 Auburn Hills, MI-ba...) will be installing its locker system and patent-... at the U.S. Department of Health and Human Servic...ethesda, MD. The locker system will support the N...rotecting our nation,s medical research agency. T...
(Date:11/5/2009)...State University has been awarded a training grant...ce Foundation under its Integrative Graduation Edu... is the first IGERT grant to be awarded to Kent St... Recovery and Reinvestment Act of 2009, runs throu... focuses on environment aquatic resource sensing (...
(Date:11/4/2009)...ouis, MO, November 4, 2009 Childhood obesity in t... With more than one fourth of advertising on dayti...beverages and continuing questions about the role ...er/December issue of the Journal of Nutrition Edu... aimed at children might be a large contributor to...
Breaking Biology News(10 mins):Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Cradle and birthday of dog identified 9751 1All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 1All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 2All Eyes on The Medical Home 3A Patient Centered Primary Care Collaborative Convenes National Summit In Washington DC 55867 3AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE 55863 1AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE 55863 2AMR Research Analyst Named One of the Most Inspiring Individuals in Life Sciences by PharmaVOICE 55863 3
...versity reveals that doctors treating life-threate...the wrong dosage of adrenaline (epinephrine) becau... in salt water in glass ampoules which are broken ...aline contained in the ampoule is usually expresse...t water) and a ratio (1 part drug for every 1000 p...
...or patients with hepatitis C, having a low blood p...d with advanced disease. This problem is compounde...r the disease can further reduce platelet numbers ...se patients the treatment they urgently need. Now,...Medicine finds that a new drug, eltrombopag, appea...
...Human Genome Project and other studies linking hum...mous amount of research producing powerful evidenc...ticist Daniel J. Fairbanks explores some of the ma...erson on the planet in RELICS OF EDEN: THE POWERFU...ooks, $24.95). , This book comes at a time when t...
Other Biology News:Doctors may be giving the wrong dosage of adrenaline in an emergency because of labelling 2Eltrombopag effective for hepatitis C patients with low blood-platelet counts 2Eltrombopag effective for hepatitis C patients with low blood-platelet counts 3There is powerful evidence of evolution in human DNA 2
EZ-Chip from Upstate
...or the PDS-1000 He biolistic system enables 7-10 t...d system. It fits into the shocking chamber of the...ock wave over 7 microcarriers. By uniformly spread... this larger area, the system maximizes the number...
Acetyl-Histone H3 Immunoprecipitation (ChIP) Assay Kit from Upstate
...itochondrial transmembrane potential is one of the...g induction of apoptosis. The MitoLight Apoptosis...d as MitoLight, as a mitochondrial activity marker...ochondria in living cells in a membrane potential-...
Biology Products: